Skip to main content
Log in

Cytostatic drug testing in human leukemias by means of multiparametric flow cytometry

  • Original Articles
  • Published:
Blut Aims and scope Submit manuscript

Summary

Human bone marrow cells from 20 patients as well as the permanent human B-cell lines RPMI 1788, Raji, Daudi, T-cell lines Molt, CEM, Jurkat and the promyelocytic line HL 60 were assayed by means of a newly developed in vitro flow cytometric cytostatic drug assay. The cells were exposed to cytosine-arabinoside, L-asparaginase, daunorubicin, prednisone or vincristine. Surviving cells were stained after an incubation period of 2 to 7 days with esterase and pH-indicator dye ADB (1,4-diacetoxy-2,3-dicyanobenzene), dead cells with DNA-dye PI (propidium iodide). Dose-response curves were established using percent surviving cells. It was possible to evaluate bone marrow samples from 16 out of 20 patients. Seven samples were leukemic (acute myeloid leukemia (AML) n=6, Non-Hodgkin's Lymphoma (NHL) n=1). Nine samples were from patients either in complete remission or with benign diseases. Daunorubicin and cytosine-arabinoside were cytotoxic in both groups, whereas vincristine was effective mainly in the leukemic group (p<0.05). There was significant heterogeneity in the reactivity of AML-marrow cells from different patients to different drugs. The cell lines exhibited different patterns of sensitivity. Vincristine arrested cells in G2/M-phase, cytosine-arabinoside caused an increase of cells in the S-phase.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Andreeff M, Darzynkiewicz Z, Sharpless T, Clarkson B, Melamed MR (1980) Discrimination of human leukemia subtypes by flow cytometric analysis of cellular DNA and RNA. Blood 55: 282–293

    CAS  PubMed  Google Scholar 

  2. Barlogie B, Raber MN, Schumann J, Johnson TS, Drewinko B, Swartzendruber DE, Göhde W, Andreeff M, Freireich EJ (1983) Flow cytometry in clinical cancer research. Cancer Res 43: 3982–3997

    CAS  PubMed  Google Scholar 

  3. Beck HP (1981) Proliferation kinetics of pertubed cell populations determined by the BrdU-33258 technique: radiotoxic effects of H3-thymidine. Cytometry 2: 170–174

    CAS  PubMed  Google Scholar 

  4. Dow LW, Dahl GV, Kalwinsky DK, Mirro J, Nash MB, Roberson PK (1986) Correlation of drug sensitivity in vitro with clinical responses in childhood acute myeloid leukemia. Blood 68: 400–405

    CAS  PubMed  Google Scholar 

  5. Durie BGM (1984) Experimental approaches to drug testing and clonogenic growth: Results in multiple myeloma and acute myelogenous leukemia. Recent Results Cancer Res 94: 93–101

    CAS  PubMed  Google Scholar 

  6. Hamburger AW, Salmon SE, Kim MB (1978) Direct cloning of human ovarian cancer cells in agar. Cancer Res 38: 3438–3444

    CAS  PubMed  Google Scholar 

  7. Heppner GH, Dexter DL, DeNucci T, Miller FR, Calabresi P (1978) Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor. Cancer Res 38: 3758–3763

    CAS  PubMed  Google Scholar 

  8. Kachel V, Glossner E, Kordwig E, Ruhenstroth-Bauer G (1977) Fluvo-Metricell, a combined cell volume and cell fluorescence analyzer. J Histochem Cytochem 25: 804–812

    CAS  PubMed  Google Scholar 

  9. Karon M, Bendict WF, Rucker N (1972) Mechanism of 1-b-D-arabinofuranosylcytosine-induced cell lethality. Cancer Res 32: 2612–2615

    CAS  PubMed  Google Scholar 

  10. Look AT, Melvin SC, Williams DL, Brodeur GM, Dahl GV, Kalwinsky Murphy SB, Maura M (1982) Aneuploidy detected by flow cytometry correlates with cell phenotype in childhood acute leukemia. Blood 60: 959–967

    CAS  PubMed  Google Scholar 

  11. Manta V, Valet G (1985) Automated sample preparation for flow-cytometry by a small robot-arm. Meeting of International Conference of Analytical Cytology XI, Hilton Head, South Carolina, USA, p 319 (abstr)

    Google Scholar 

  12. Park CH, Wiernik PH, Morrison FS, Amare M, Sloten KV, Maloney TR (1983) Clinical correlations of leukemic clonogenic cell chemosensitivity assessed by in vitro continuous exposure to drugs. Cancer Res 43: 2346–2349

    CAS  PubMed  Google Scholar 

  13. Possinger K, Ehrhart H (1983) Prädiktive Tumorteste im chemotherapeutischen Behandlungskonzept maligner Erkrankungen. Klin Wochenschr 61: 77–84

    Article  CAS  PubMed  Google Scholar 

  14. Preisler HD (1980) Prediction of response to chemotherapy in acute myelocytic leukemia. Blood 56: 361–367

    CAS  PubMed  Google Scholar 

  15. Sanfilippo O, Daidone MG, Silvestrini R (1979) Antimetabolic effect of drugs in short-term culture as a potential tool for monitoring tumor chemosensitivity. Chemother Oncol 4: 261–265

    Google Scholar 

  16. Schwarzmeier JD, Pirker R, Paietta E (1984) Short-term in vitro testing in acute leukemia. Recent Results Cancer Res 94: 116–126

    CAS  PubMed  Google Scholar 

  17. Steel GG, Courtenay VD, Peckham MJ (1983) The response to chemotherapy of a variety of human tumor xenografts. Br J Cancer 47: 1–13

    CAS  PubMed  Google Scholar 

  18. Suarez C, Miller D, Andreeff M (1981) Flow cytometry for DNA and RNA determination in 107 cases of childhood ALL: correlation with FAB Classification. Proc Am Ass Cancer Res 22: (abstr. 770)

    Google Scholar 

  19. Ugelstad J, Mork PC, Herder Kaggerud K, Ellingson T, Berge A (1980) Swelling of oligomer-polymer particles. New methods of preparation of emulsions and polymer dispersions. Adv Coll Interf Sci 13: 101–140

    Article  CAS  Google Scholar 

  20. Valet G (1980) Graphical representation of three parameter flow cytometer histograms by a newly developed FORTRAN IV computer program. In: Flow cytometry IV, Oslo, Universitetsforlaget, pp 125–129

    Google Scholar 

  21. Valet G, Raffael A, Moroder L, Wünsch E, Ruhenstroth-Bauer G (1981) Fast intracellular pH determination in single cells by flow-cytometry. Naturwissenschaften 68: 265–266

    Article  CAS  PubMed  Google Scholar 

  22. Valet G, Warnecke HH, Kahle H (1984) New possibilities of cytostatic drug testing on patient tumor cells by flow cytometry. Blut 49: 37–43

    CAS  PubMed  Google Scholar 

  23. Valet G, Raffael A (1984) Determination of intracellular pH and esterase activity in vital cells by flow cytometry. In: Cyto-P-Check, Paesel GmbH, Frankfurt, pp 3–22

    Google Scholar 

  24. Valet G (1987) Automated diagnosis of malignant and other abnormal cells by flow cytometry using the DIAGNOS I program system. In: Burger G, Ploem JS, Goerttler K (eds) Clin cytometry histometry. Academic Press, London, pp 58–66

    Google Scholar 

  25. Warnecke HH, Kahle H, Valet G (1984) Durchflußzytometrische Zytostatikatestung an Patientenzellen gynäkologischer Tumoren. In: Nagel GA, Sauer R, Schreiber HW (eds) Aktuelle Onkologie, vol 16. München, Zuckschwerdt Verlag, pp 101–107

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was supported in part by grant (Ne 310/1-1) from the Deutsche Forschungsgemeinschaft

Rights and permissions

Reprints and permissions

About this article

Cite this article

Neubauer, A., Sauer, H. & Valet, G. Cytostatic drug testing in human leukemias by means of multiparametric flow cytometry. Blut 55, 433–445 (1987). https://doi.org/10.1007/BF00367460

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00367460

Key words

Navigation